IL165452A0 - Use of CETP inhibitors and antihypertensive agentsas well as optionally HMG COA reductase inhibitor s - Google Patents

Use of CETP inhibitors and antihypertensive agentsas well as optionally HMG COA reductase inhibitor s

Info

Publication number
IL165452A0
IL165452A0 IL16545204A IL16545204A IL165452A0 IL 165452 A0 IL165452 A0 IL 165452A0 IL 16545204 A IL16545204 A IL 16545204A IL 16545204 A IL16545204 A IL 16545204A IL 165452 A0 IL165452 A0 IL 165452A0
Authority
IL
Israel
Prior art keywords
agentsas
antihypertensive
well
coa reductase
reductase inhibitor
Prior art date
Application number
IL16545204A
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Priority to IL16545204A priority Critical patent/IL165452A0/en
Publication of IL165452A0 publication Critical patent/IL165452A0/en

Links

IL16545204A 2004-11-29 2004-11-29 Use of CETP inhibitors and antihypertensive agentsas well as optionally HMG COA reductase inhibitor s IL165452A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL16545204A IL165452A0 (en) 2004-11-29 2004-11-29 Use of CETP inhibitors and antihypertensive agentsas well as optionally HMG COA reductase inhibitor s

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL16545204A IL165452A0 (en) 2004-11-29 2004-11-29 Use of CETP inhibitors and antihypertensive agentsas well as optionally HMG COA reductase inhibitor s

Publications (1)

Publication Number Publication Date
IL165452A0 true IL165452A0 (en) 2006-01-15

Family

ID=37215659

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16545204A IL165452A0 (en) 2004-11-29 2004-11-29 Use of CETP inhibitors and antihypertensive agentsas well as optionally HMG COA reductase inhibitor s

Country Status (1)

Country Link
IL (1) IL165452A0 (en)

Similar Documents

Publication Publication Date Title
IL165328A0 (en) Use of cetp inhibitors and optionally hmg coa reductase inhibitors and/or antihypertensive agents
PL374364A1 (en) Use of cetp inhibitors and antihypertensive agents as well as optionally hmg coa reductase inhibitors
EP1711193A4 (en) IMPROVING PROFILES OF LIPID PROTEINS AND INHIBITING HMG-CoA REDUCTASE
ZA201203844B (en) Heterocyclic inhibitors of mek and methods of use thereof
EP1831207A4 (en) Aminopyrimidine compounds and methods of use
IL181524A0 (en) Heterocyclic compounds and methods of use
EP1684754A4 (en) Hmg-coa reductase inhibitors and method
EP1742627A4 (en) Pde4b inhibitors and uses therefor
EP1756092A4 (en) Novel inhibitors of rho-kinases
IL185914A0 (en) Pyrimidine compounds and methods of use
HK1208865A1 (en) Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors 6 pde4
EP1940787A4 (en) Novel ido inhibitors and methods of use thereof
IL177012A0 (en) Quinoline derivatives and use thereof as mycobacterial inhibitors
IL173936A0 (en) Heterocyclic inhibitors of mek and methods of use thereof
EP1996118A4 (en) Hmg co-a reductase inhibitor enhancement of bone and cartilage
IL163929A0 (en) Combination comprising an hmg-coa reductase inhibitor and an insulin secretor enhancer or an insulinsensitizer
EP1799682A4 (en) Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof
EP1812451A4 (en) Compounds and methods of use thereof
EP1812019A4 (en) Combination of polychitosamine and hmg-coa reductase inhibitor for hyperlipidemia
IL192594A0 (en) Combination of triazine derivatives and hmg-coa reductase inhibitors
IL186120A0 (en) Inhibitors of neurotrypsin and determination thereof
GB2416174B (en) An article for increasing titanium content of steel
EP2049102A4 (en) Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof
IL180619A0 (en) Provision of location information into iri
HK1081843A1 (en) Pharmaceutical composition comprising reductase inhibitor hmg-coa and melatonin